ATE489466T1 - Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon - Google Patents
Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davonInfo
- Publication number
- ATE489466T1 ATE489466T1 AT02736569T AT02736569T ATE489466T1 AT E489466 T1 ATE489466 T1 AT E489466T1 AT 02736569 T AT02736569 T AT 02736569T AT 02736569 T AT02736569 T AT 02736569T AT E489466 T1 ATE489466 T1 AT E489466T1
- Authority
- AT
- Austria
- Prior art keywords
- hairless protein
- inhibiting
- nucleic acids
- protein expression
- provides
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 abstract 2
- 102000053642 Catalytic RNA Human genes 0.000 abstract 2
- 108090000994 Catalytic RNA Proteins 0.000 abstract 2
- 108091027757 Deoxyribozyme Proteins 0.000 abstract 2
- 239000000074 antisense oligonucleotide Substances 0.000 abstract 2
- 238000012230 antisense oligonucleotides Methods 0.000 abstract 2
- 108020004999 messenger RNA Proteins 0.000 abstract 2
- 108091092562 ribozyme Proteins 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28361801P | 2001-04-13 | 2001-04-13 | |
| PCT/US2002/011683 WO2002083891A2 (en) | 2001-04-13 | 2002-04-12 | Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE489466T1 true ATE489466T1 (de) | 2010-12-15 |
Family
ID=23086858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02736569T ATE489466T1 (de) | 2001-04-13 | 2002-04-12 | Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US7423022B2 (de) |
| EP (2) | EP1385948B1 (de) |
| JP (1) | JP2005510204A (de) |
| AT (1) | ATE489466T1 (de) |
| DE (1) | DE60238395D1 (de) |
| WO (1) | WO2002083891A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1385948B1 (de) * | 2001-04-13 | 2010-11-24 | The Trustees of Columbia University in the City of New York | Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon |
| US20050233996A1 (en) * | 2002-02-20 | 2005-10-20 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of hairless (HR) gene expression using short interfering nucleic acid (siNA) |
| CA2522184A1 (en) * | 2003-04-17 | 2004-11-04 | The Trustees Of Columbia University In The City Of New York | Desmoglein 4 is a novel gene involved in hair growth |
| US8168600B2 (en) | 2004-04-23 | 2012-05-01 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
| CA2557532A1 (en) | 2004-04-23 | 2005-11-10 | Angela M. Christiano | Inhibition of hairless protein mrna |
| DE102004025881A1 (de) * | 2004-05-19 | 2006-01-05 | Beiersdorf Ag | Oligoribonukleotide zur Beeinflussung des Haarwachstums |
| US8568797B2 (en) | 2011-09-13 | 2013-10-29 | Avon Products, Inc | Method for enhancing the growth and fullness of hair |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US283618A (en) | 1883-08-21 | la mont | ||
| EP1053315A4 (de) * | 1998-01-29 | 2003-07-30 | Univ Columbia | Menschliches 'haarlos'-gen und -protein und ihre verwendungen |
| US6348348B1 (en) * | 1998-04-07 | 2002-02-19 | The Carnegie Institution Of Washington | Human hairless gene and protein |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| EP1385948B1 (de) * | 2001-04-13 | 2010-11-24 | The Trustees of Columbia University in the City of New York | Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon |
-
2002
- 2002-04-12 EP EP02736569A patent/EP1385948B1/de not_active Expired - Lifetime
- 2002-04-12 WO PCT/US2002/011683 patent/WO2002083891A2/en active Application Filing
- 2002-04-12 DE DE60238395T patent/DE60238395D1/de not_active Expired - Lifetime
- 2002-04-12 EP EP10184165A patent/EP2327784A3/de not_active Withdrawn
- 2002-04-12 AT AT02736569T patent/ATE489466T1/de not_active IP Right Cessation
- 2002-04-12 US US10/122,013 patent/US7423022B2/en not_active Expired - Fee Related
- 2002-04-12 JP JP2002582229A patent/JP2005510204A/ja active Pending
-
2008
- 2008-06-16 US US12/139,818 patent/US20090004169A1/en not_active Abandoned
-
2010
- 2010-03-01 US US12/715,207 patent/US8008471B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1385948A4 (de) | 2005-07-20 |
| WO2002083891A3 (en) | 2002-12-12 |
| DE60238395D1 (de) | 2011-01-05 |
| US8008471B2 (en) | 2011-08-30 |
| JP2005510204A (ja) | 2005-04-21 |
| EP1385948A2 (de) | 2004-02-04 |
| EP2327784A2 (de) | 2011-06-01 |
| EP2327784A3 (de) | 2012-11-28 |
| WO2002083891A2 (en) | 2002-10-24 |
| US20100221318A1 (en) | 2010-09-02 |
| US7423022B2 (en) | 2008-09-09 |
| US20030077614A1 (en) | 2003-04-24 |
| EP1385948B1 (de) | 2010-11-24 |
| US20090004169A1 (en) | 2009-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE430759T1 (de) | Kationische sterolderivate, ph-sensitive liposomen diese umfassend und verfahren zur wirkstoffbeladung von liposomen | |
| DE60210265D1 (de) | Verfahren und zwischenprodukte zur herstellung von 4-aminochinolin-cetp-inhibitoren | |
| CY1116385T1 (el) | Αντινοηματικη διαμορφωση της εκφρασης της απολιποπρωτεινης β | |
| CY1110177T1 (el) | Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης | |
| ZA979550B (en) | Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them. | |
| ATE269295T1 (de) | Btk inhibitoren und verfahren zur identifizierung und verwendung | |
| DE602004031462D1 (de) | Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung | |
| ATE428780T1 (de) | Verfahren zur zubereitung von antisense oligonukleotiden | |
| DE69432315D1 (de) | ANTISENSE NUKLEINSÄUREN ZUR VORBEUGUNG UND BEHANDLUNG VON BESCHWERDEN IN WELCHEN DIE EXPRIMIERUNG VON C-erbB-2 EINE ROLLE SPIELT | |
| BRPI0408466A (pt) | composições farmacêuticas de inibidores de cetp e uso dos referidos inibidores | |
| WO2003022222A3 (en) | Antisense modulation of protein kinase r expression | |
| ATE489466T1 (de) | Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon | |
| ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| DE60032002D1 (de) | Verfahren zur herstellung von antimikrobiellen parfümierenden zusammensetzungen | |
| WO2003057843A3 (en) | Methods and materials for modulating trpc4 | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| HUP0102614A2 (hu) | Az angiogenezis módosítására alkalmas, SRC tirozin kinázt hasznosító eljárások és kompozíciók | |
| HUP0402327A2 (hu) | Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása | |
| DE60134234D1 (de) | Nukleinsäurekonstrukte, damit transformierte vaskuläre zellen, pharmezeutische zusammensetzungen und verfahren zur induktion der angiogenese | |
| DE60333747D1 (de) | Dna-enzym zur hemmung von plasminogenaktivator-inhibitor-1 | |
| DE69823275T2 (de) | Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Arzneimitteln | |
| BR0013228A (pt) | Método e composições utilizados para modulação de angiogenese usando proteìna quinase raf e ras | |
| WO2003057847A8 (en) | METHODS AND MATERIALS FOR MODULATING ENaC-BETA | |
| DE60110807D1 (de) | Kontinuierliches verfahren zur herstellung von pestiziden chlorthiazolen | |
| DE50205026D1 (de) | Verfahren zur herstellung von n-substituierten 2,6-dialkylmorpholinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |